Abstract
There is an increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) in the western world due to human papillomavirus (HPV). According to the Danish Head and Neck Cancer Group guidelines, the current recommended treatment of patients with OPSCC in Denmark is primary radiation therapy (RT) with or without concomitant chemotherapy. This is the first study in Scandinavia from a head and neck cancer centre that aims to demonstrate the feasibility of performing primary transoral robotic surgery (TORS) and concurrent neck dissection for patients with early stage OPSCC. Between September 2014 and January 2016, 30 consecutive patients with clinical T1–T2, N0–N1 OPSCC underwent primary TORS and concurrent neck dissection. The patients were offered postoperative adjuvant therapy according to pathological risk parameters: pT >2, T-site margin <2 mm, pN >1 or extracapsular extension (ECE). Concomitant chemotherapy was offered to patients with the presence of ECE or involved margins. Twenty-nine patients had negative margins on T-site after primary resection. Only one patient had a close margin of 1 mm. Unilateral neck dissection was performed in 21 patients while nine patients underwent bilateral neck dissection. Due to an upstaging following surgery, 13 patients were referred to adjuvant therapy. Four of these patients received RT and two patients received concomitant chemo-radiation (CCR) therapy. Seven patients declined the recommended adjuvant therapy one of whom later developed an N-site recurrence and received salvage surgery with postoperative RT. In summary, 43% of the patients were referred to adjuvant therapy following primary surgery which was mainly due to N-site stage migration and ECE. Primary TORS and concurrent neck dissection is a safe and feasible procedure that may be an alternative to primary RT and CCR in a selected group of patients with early stage OPSCC.
Similar content being viewed by others
References
Garnaes E, Kiss K, Andersen L et al (2015) Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. Br J Cancer, Nature Publishing Group 113:131–134
Garnaes E, Kiss K, Andersen L et al (2014) A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000–2010: the largest registry-based study to date. Int J Cancer 136:2196–2203
Grønhøj Larsen C, Jensen DH, Fenger Carlander A-L et al (2016) Novel nomograms for survival and progression in HPV+ and HPV− oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget 7(44):71761–71772
Garnaes E, Frederiksen K, Kiss K et al (2016) Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: insights from a large population-based study. Int J Cancer 139:2598–2605
Danish Head and Neck Cancer Group (Internet). https://www.dahanca.oncology.dk/. Accessed 1 Sept 2016
Yeh DH, Tam S, Fung K et al (2015) Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma—a systematic review of the literature. Eur J Surg Oncol (Elsevier Ltd) 41:1603–1614
Weinstein GS, Quon H, Newman HJ et al (2012) Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg 138:628–634
Lörincz BB, Möckelmann N, Busch C-J et al (2015) Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Head Neck 37:1618–1624
van Loon JWL, Smeele LE, Hilgers FJM et al (2015) Outcome of transoral robotic surgery for stage I–II oropharyngeal cancer. Eur Arch Oto Rhino Laryngol 272:175–183
Kelly K, Johnson-Obaseki S, Lumingu J et al (2014) Oncologic, functional and surgical outcomes of primary transoral robotic surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol (Elsevier Ltd) 50:696–703
de Almeida JR, Byrd JK, Wu R et al (2014) A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope 124:2096–2102
Wang MB, Liu IY, Gornbein JA et al (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg 153:758–769
De Almeida JR, Li R, Magnuson JS et al (2015) Oncologic outcomes after transoral robotic surgery: a multi-institutional study. JAMA Otolaryngol Head Neck Surg 141:1043–1051
Owadally W, Hurt C, Timmins H et al (2015) PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer 15:602
Nichols AC, Yoo J, Hammond JA et al (2013) Early stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)—study protocol for a randomized phase II trial. BMC Cancer 13:133
Channir HI, Rubek N, Nielsen HU et al (2015) Transoral robotic surgery for the management of head and neck squamous cell carcinoma of unknown primary. Acta Otolaryngol 135:1051–1057
Barnes L, Iveson JW, Reichart P et al (2005) World Health Organization classification of tumors: pathology and genetics head and neck tumours. IARC Press, Lyon
Weinstein GS, O’Malley BW Jr, Snyder W et al (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Head Neck Surg 133:1220–1226
Moore EJ, Olsen KD, Martin EJ (2011) Concurrent neck dissection and transoral robotic surgery. Laryngoscope 121:541–544
Huang SH, Hansen A, Rathod S et al (2015) Primary surgery versus (chemo)radiotherapy in oropharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg 23:139–147
De Almeida JR, Moskowitz AJ, Miles BA et al (2016) Cost-effectiveness of transoral robotic surgery versus (chemo) radiotherapy for early T classification oropharyngeal carcinoma: a cost-utility analysis. Head Neck 38:589–600
Rudmik L, An W, Livingstone D et al (2015) Making a case for high-volume robotic surgery centers: a cost-effectiveness analysis of transoral robotic surgery. J Surg Oncol 112:155–163
Choby GW, Kim J, Ling DC et al (2015) Transoral robotic surgery alone for oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 141:499–504
Dziegielewski PT, Teknos TN, Durmus K et al (2013) Transoral robotic surgery for oropharyngeal cancer. JAMA Otolaryngol Neck Surg 139(11):1099–108
Hutcheson KA, Holsinger FC, Kupferman ME et al (2015) Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol 272:463–471
Dawe N, Patterson J, O’Hara J (2016) Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Clin Otolaryngol 41(4):371–85
Chen A, Daly M, Luu Q et al (2015) Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer. Head Neck 37:381–385
Haughey BH, Sinha P (2012) Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 122:S13–S33
Weinstein GS, Quon H, O’Malley BW Jr et al (2010) Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 120:1749–1755
Sinha P, Lewis JS, Piccirillo JF et al (2012) Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 118:3519–3530
Acknowledgements
None to state.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial disclosures
The Da Vinci SI HD robot was obtained through a grant from The Candys Foundation, a non-profit foundation. HIC salary in PhD project was also funded by The Candys Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Rubek, N., Channir, H.I., Charabi, B.W. et al. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Eur Arch Otorhinolaryngol 274, 2229–2237 (2017). https://doi.org/10.1007/s00405-016-4433-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-4433-3